AA
IOVA icon

ALPS Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

ALPS Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-86,118
Closed -$825K – 1059
2022
Q3 		$825K Sell
86,118
-7,118
-8% -$82.1K 0.01% 506
2022
Q2 		$1.03M Sell
93,236
-68,292
-42% -$895K 0.01% 469
2022
Q1 		$2.69M Sell
161,528
-17,891
-10% -$277K 0.03% 174
2021
Q4 		$3.42M Sell
179,419
-10,600
-6% -$233K 0.04% 177
2021
Q3 		$4.69M Sell
190,019
-10,411
-5% -$245K 0.05% 178
2021
Q2 		$5.21M Buy
+200,430
New +$5.21M 0.05% 173

Other funds holding IOVA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return